# OnCo record paper-nct04585750-n-engl-j-med-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct04585750-n-engl-j-med-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct04585750-n-engl-j-med-2026" ;
  schema:name "Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors"@en ;
  schema:description "Published report from the PYNNACLE trial registered as NCT04585750, in New England Journal of Medicine (2026), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct04585750-n-engl-j-med-2026/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa2508820>, <https://pubmed.ncbi.nlm.nih.gov/41740031/>, <https://europepmc.org/article/MED/41740031>, <https://clinicaltrials.gov/study/NCT04585750> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa2508820> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Dumbrava EE, Shapiro GI, Parikh AR, et al." ;
  onco:trials <https://onco.cc/trials/nct04585750/> ;
  onco:journals <https://onco.cc/journals/nejm/> .